SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-028848
Filing Date
2023-08-10
Accepted
2023-08-10 16:09:35
Documents
16
Period of Report
2023-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K advm-20230810.htm   iXBRL 8-K 25942
2 EX-99.1 exhibit991_81023pressrelea.htm EX-99.1 32118
6 GRAPHIC isqtdq223.jpg GRAPHIC 85060
7 GRAPHIC logo.jpg GRAPHIC 9327
8 GRAPHIC q2bsa.jpg GRAPHIC 1073084
  Complete submission text file 0001628280-23-028848.txt   1799347

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT advm-20230810.xsd EX-101.SCH 1901
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT advm-20230810_lab.xml EX-101.LAB 23834
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT advm-20230810_pre.xml EX-101.PRE 12508
10 EXTRACTED XBRL INSTANCE DOCUMENT advm-20230810_htm.xml XML 2695
Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36579 | Film No.: 231159402
SIC: 2836 Biological Products, (No Diagnostic Substances)